Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan M Rapoport

Showing results (61-70 of 118) with videos related to

Pageof 12
Sort By:
Current Pain and Headache Reports|August 6, 2013
Why does vomiting stop a migraine attack?Nu Cindy Chai, Robert E Shapiro, Alan M Rapoport
Current Pain and Headache Reports|December 26, 2001
Ethical considerations in cluster headache researchStewart J Tepper, Alan M Rapoport, Fred D Sheftell
Neurology|February 26, 2004
Analgesic use: a predictor of chronic pain in medication overuse headache: the Head-HUNT studyFred D Sheftell, Stewart J Tepper, Alan M Rapoport
Cephalalgia : an International Journal of Headache|August 30, 2014
Commentary on Westergaard's "Definitions of medication-overuse headache in population-based studies and their implications on prevalence estimates: A systematic review"Alan M Rapoport, Chelsea A Meskunas, Marcelo E Bigal
Pain Management|August 6, 2020
Development of a novel zolmitriptan intracutaneous microneedle system (Qtrypta™) for the acute treatment of migraineAlan M Rapoport, Mahmoud Ameri, Hayley Lewis, et al.
The Journal of Headache and Pain|August 17, 2018
Efficacy and safety of DFN-11 (sumatriptan injection, 3 mg) in adults with episodic migraine: a multicenter, randomized, double-blind, placebo-controlled studyStephen Landy, Sagar Munjal, Elimor Brand-Schieber, et al.
CNS Drugs|May 18, 2021
The Evolution of Medication Overuse Headache: History, Pathophysiology and Clinical UpdateChristina Sun-Edelstein, Alan M Rapoport, Wanakorn Rattanawong, et al.
Headache|September 13, 2013
Intranasal zolmitriptan for the treatment of acute migraineStewart J Tepper, Susy Chen, Faith Reidenbach, et al.
The Journal of Headache and Pain|August 17, 2018
Efficacy and safety of DFN-11 (sumatriptan injection, 3 mg) in adults with episodic migraine: an 8-week open-label extension studyStephen Landy, Sagar Munjal, Elimor Brand-Schieber, et al.
Clinical Pharmacology : Advances and Applications|September 14, 2016
The effect of weight, body mass index, age, sex, and race on plasma concentrations of subcutaneous sumatriptan: a pooled analysisSagar Munjal, Anirudh Gautam, Alan M Rapoport, et al.
Pageof 12

Showing results (61-70 of 118) with videos related to

Sort By:
Pageof 12
Current Pain and Headache Reports|August 6, 2013
Why does vomiting stop a migraine attack?Nu Cindy Chai, Robert E Shapiro, Alan M Rapoport
Current Pain and Headache Reports|December 26, 2001
Ethical considerations in cluster headache researchStewart J Tepper, Alan M Rapoport, Fred D Sheftell
Neurology|February 26, 2004
Analgesic use: a predictor of chronic pain in medication overuse headache: the Head-HUNT studyFred D Sheftell, Stewart J Tepper, Alan M Rapoport
Cephalalgia : an International Journal of Headache|August 30, 2014
Commentary on Westergaard's "Definitions of medication-overuse headache in population-based studies and their implications on prevalence estimates: A systematic review"Alan M Rapoport, Chelsea A Meskunas, Marcelo E Bigal
Pain Management|August 6, 2020
Development of a novel zolmitriptan intracutaneous microneedle system (Qtrypta™) for the acute treatment of migraineAlan M Rapoport, Mahmoud Ameri, Hayley Lewis, et al.
The Journal of Headache and Pain|August 17, 2018
Efficacy and safety of DFN-11 (sumatriptan injection, 3 mg) in adults with episodic migraine: a multicenter, randomized, double-blind, placebo-controlled studyStephen Landy, Sagar Munjal, Elimor Brand-Schieber, et al.
CNS Drugs|May 18, 2021
The Evolution of Medication Overuse Headache: History, Pathophysiology and Clinical UpdateChristina Sun-Edelstein, Alan M Rapoport, Wanakorn Rattanawong, et al.
Headache|September 13, 2013
Intranasal zolmitriptan for the treatment of acute migraineStewart J Tepper, Susy Chen, Faith Reidenbach, et al.
The Journal of Headache and Pain|August 17, 2018
Efficacy and safety of DFN-11 (sumatriptan injection, 3 mg) in adults with episodic migraine: an 8-week open-label extension studyStephen Landy, Sagar Munjal, Elimor Brand-Schieber, et al.
Clinical Pharmacology : Advances and Applications|September 14, 2016
The effect of weight, body mass index, age, sex, and race on plasma concentrations of subcutaneous sumatriptan: a pooled analysisSagar Munjal, Anirudh Gautam, Alan M Rapoport, et al.
Pageof 12